Jazz Pharmaceuticals Announces Phase III Clinical Trial to Study the Safety and Efficacy of
Xyrem(R) (Sodium Oxybate) in Patients With Fibromyalgia Syndrome.

The randomized, double-blind, placebo-controlled study will evaluate the safety and efficacy of
Xyrem compared to placebo for the treatment of fibromyalgia and its symptoms. The study will
enroll both males and females, 18 years of age or older, who meet the American College of
Rheumatology (ACR) diagnostic criteria for fibromyalgia.

Individuals who believe they may qualify to enroll in the study, or their physicians, should
visit http://www.clinicaltrials.gov for information about study sites.              This from FibroHugs.com

 

Currently there are quite a long list of clinical trials for Fibromyalgia patients

 

http://www.clinicaltrials.gov/    then search for "Fibromyalgia"